Literature DB >> 2779549

Molecular cloning, sequence analysis, and functional expression of a novel growth regulator, oncostatin M.

N Malik1, J C Kallestad, N L Gunderson, S D Austin, M G Neubauer, V Ochs, H Marquardt, J M Zarling, M Shoyab, C M Wei.   

Abstract

Oncostatin M is a polypeptide of Mr approximately 28,000 that acts as a growth regulator for many cultured mammalian cells. We report the cDNA and genomic cloning, sequence analysis, and functional expression in heterologous cells of oncostatin M. cDNA clones were isolated from mRNA of U937 cells that had been induced to differentiate into macrophagelike cells by treatment with phorbol 12-myristate 13-acetate, and a genomic clone was also isolated from human brain DNA. Sequence analysis of these clones established the 1,814-base-pair cDNA sequence as well as exon boundaries. This sequence predicted that oncostatin M is synthesized as a 252-amino-acid polypeptide, with a 25-residue hydrophobic sequence resembling a signal peptide at the N terminus. The predicted oncostatin M amino acid sequence shared no homology with other known proteins, but the sequence of the 3' noncoding region of the cDNA contained an A + T-rich stretch with sequence motifs found in the 3' untranslated regions of many cytokine and lymphokine cDNAs. Oncostatin M mRNA of approximately 2 kilobase pairs was detected in phorbol 12-myristate 13-acetate-treated U937 cells and in activated human T cells. Transfection of cDNA encoding the oncostatin M precursor into COS cells resulted in the secretion of proteins with the structural and functional properties of oncostatin M. The unique amino acid sequence, expression by lymphoid cells, and growth-regulatory activities of oncostatin M suggest that it is a novel cytokine.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2779549      PMCID: PMC362750          DOI: 10.1128/mcb.9.7.2847-2853.1989

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  38 in total

1.  Structural homologies among the hemopoietins.

Authors:  J W Schrader; H J Ziltener; K B Leslie
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

2.  Short-term, high-efficiency expression of transfected DNA.

Authors:  D J Sussman; G Milman
Journal:  Mol Cell Biol       Date:  1984-08       Impact factor: 4.272

3.  Synthetic oligonucleotide probes deduced from amino acid sequence data. Theoretical and practical considerations.

Authors:  R Lathe
Journal:  J Mol Biol       Date:  1985-05-05       Impact factor: 5.469

4.  Identification and characterization of cellular receptors for the growth regulator, oncostatin M.

Authors:  P S Linsley; M Bolton-Hanson; D Horn; N Malik; J C Kallestad; V Ochs; J M Zarling; M Shoyab
Journal:  J Biol Chem       Date:  1989-03-15       Impact factor: 5.157

5.  Identification of a novel serum protein secreted by lung carcinoma cells.

Authors:  P S Linsley; D Horn; H Marquardt; J P Brown; I Hellström; K E Hellström; V Ochs; E Tolentino
Journal:  Biochemistry       Date:  1986-05-20       Impact factor: 3.162

6.  Primary structure of the human melanoma-associated antigen p97 (melanotransferrin) deduced from the mRNA sequence.

Authors:  T M Rose; G D Plowman; D B Teplow; W J Dreyer; K E Hellström; J P Brown
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

7.  Human transforming growth factor-beta complementary DNA sequence and expression in normal and transformed cells.

Authors:  R Derynck; J A Jarrett; E Y Chen; D H Eaton; J R Bell; R K Assoian; A B Roberts; M B Sporn; D V Goeddel
Journal:  Nature       Date:  1985 Aug 22-28       Impact factor: 49.962

8.  Human GM-CSF: molecular cloning of the complementary DNA and purification of the natural and recombinant proteins.

Authors:  G G Wong; J S Witek; P A Temple; K M Wilkens; A C Leary; D P Luxenberg; S S Jones; E L Brown; R M Kay; E C Orr
Journal:  Science       Date:  1985-05-17       Impact factor: 47.728

9.  Molecular cloning of a functional bovine interleukin 2 cDNA.

Authors:  R Reeves; A G Spies; M S Nissen; C D Buck; A D Weinberg; P J Barr; N S Magnuson; J A Magnuson
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

10.  Recombinant human tumor necrosis factor-alpha: effects on proliferation of normal and transformed cells in vitro.

Authors:  B J Sugarman; B B Aggarwal; P E Hass; I S Figari; M A Palladino; H M Shepard
Journal:  Science       Date:  1985-11-22       Impact factor: 47.728

View more
  49 in total

Review 1.  Receptor recognition by gp130 cytokines.

Authors:  J Bravo; J K Heath
Journal:  EMBO J       Date:  2000-06-01       Impact factor: 11.598

2.  Oncostatin m maintains the hematopoietic microenvironment and retains hematopoietic progenitors in the bone marrow.

Authors:  Ken-ichi Minehata; Masaki Takeuchi; Yoko Hirabayashi; Tohru Inoue; Peter J Donovan; Minoru Tanaka; Atsushi Miyajima
Journal:  Int J Hematol       Date:  2006-11       Impact factor: 2.490

3.  Fetal liver development requires a paracrine action of oncostatin M through the gp130 signal transducer.

Authors:  A Kamiya; T Kinoshita; Y Ito; T Matsui; Y Morikawa; E Senba; K Nakashima; T Taga; K Yoshida; T Kishimoto; A Miyajima
Journal:  EMBO J       Date:  1999-04-15       Impact factor: 11.598

4.  Oncostatin M is a proinflammatory mediator. In vivo effects correlate with endothelial cell expression of inflammatory cytokines and adhesion molecules.

Authors:  V Modur; M J Feldhaus; A S Weyrich; D L Jicha; S M Prescott; G A Zimmerman; T M McIntyre
Journal:  J Clin Invest       Date:  1997-07-01       Impact factor: 14.808

Review 5.  The role of interleukin-6 in the failing heart.

Authors:  K C Wollert; H Drexler
Journal:  Heart Fail Rev       Date:  2001-03       Impact factor: 4.214

Review 6.  Interleukin-6 Family Cytokines.

Authors:  Stefan Rose-John
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-02-01       Impact factor: 10.005

7.  Loss of Oncostatin M Signaling in Adipocytes Induces Insulin Resistance and Adipose Tissue Inflammation in Vivo.

Authors:  Carrie M Elks; Peng Zhao; Ryan W Grant; Hardy Hang; Jennifer L Bailey; David H Burk; Margaret A McNulty; Randall L Mynatt; Jacqueline M Stephens
Journal:  J Biol Chem       Date:  2016-06-20       Impact factor: 5.157

8.  Oncostatin M inhibits proliferation of rat oval cells, OC15-5, inducing differentiation into hepatocytes.

Authors:  Atsuhito Okaya; Junichi Kitanaka; Nobue Kitanaka; Makoto Satake; Yuna Kim; Kunihiko Terada; Toshihiro Sugiyama; Motohiko Takemura; Jiro Fujimoto; Nobuyuki Terada; Atsushi Miyajima; Tohru Tsujimura
Journal:  Am J Pathol       Date:  2005-03       Impact factor: 4.307

9.  Promoter DNA methylation of oncostatin m receptor-beta as a novel diagnostic and therapeutic marker in colon cancer.

Authors:  Myoung Sook Kim; Joost Louwagie; Beatriz Carvalho; Jochim S Terhaar Sive Droste; Hannah Lui Park; Young Kwang Chae; Keishi Yamashita; Junwei Liu; Kimberly Laskie Ostrow; Shizhang Ling; Rafael Guerrero-Preston; Semra Demokan; Zubeyde Yalniz; Nejat Dalay; Gerrit A Meijer; Wim Van Criekinge; David Sidransky
Journal:  PLoS One       Date:  2009-08-07       Impact factor: 3.240

10.  Prevalence of viremia and oral shedding of rhesus rhadinovirus and retroperitoneal fibromatosis herpesvirus in large age-structured breeding groups of rhesus macaques (Macaca mulatta).

Authors:  Jessica A White; Patricia A Todd; Joann L Yee; Alexis Kalman-Bowlus; Kelsey S Rodgers; Xiaowei Yang; Scott W Wong; Peter Barry; Nicholas W Lerche
Journal:  Comp Med       Date:  2009-08       Impact factor: 0.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.